Literature DB >> 23769436

[Immunohistochemistry using epidermal growth factor receptor mutation-specific antibodies of delE746-A750 and L858R in lung adenocarcinomas].

Xiang-shan Fan1, Biao Liu, Bo Yu, Shan-shan Shi, Xuan Wang, Jin Zhang, Jian-dong Wang, Zhen-feng Lu, Heng-hui Ma, Xiao-jun Zhou.   

Abstract

OBJECTIVE: To evaluate the immunohistochemical detection of epidermal growth factor receptor(EGFR) mutations using two EGFR mutation-specific monoclonal antibodies: delE746-A750 and L858R.
METHODS: A total of 175 paraffin-embedded lung adenocarcinoma tissue samples previously genotyped by directive DNA sequencing were subject to immunostaining using delE746-A750 and L858R antibodies.
RESULTS: There was no significant difference of mutation detection between DNA sequence analysis and delE746-A750 and/or L858R immunostaining (33.7% vs 30.9%, P > 0.05). The overall sensitivity, specificity, positive predictive value and negative predictive value of immunostaining using these two EGFR mutation-specific antibodies were 83.1%, 95.7%, 90.7% and 90.9%, respectively.
CONCLUSION: With high sensitivity and good specificity, immunohistochemistry using EGFR mutation-specific monoclonal antibodies is an adequate, easy and cost-effective prescreening method to detect EGFR mutations using paraffin-embedded tissue specimens of lung adenocarcinomas.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23769436     DOI: 10.3760/cma.j.issn.0529-5807.2013.03.007

Source DB:  PubMed          Journal:  Zhonghua Bing Li Xue Za Zhi        ISSN: 0529-5807


  1 in total

1.  A comparison of ARMS and mutation specific IHC for common activating EGFR mutations analysis in small biopsy and cytology specimens of advanced non small cell lung cancer.

Authors:  Xueqing Wang; Guoqing Wang; Yueyue Hao; Yinhong Xu; Lihua Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.